TrialsgrambetaRCTs are beautiful

IABP-SHOCK II

2012

Intra-Aortic Balloon Pump in Cardiogenic Shock

In 600 patients with MI-related cardiogenic shock undergoing revascularisation, intra-aortic balloon counterpulsation did not reduce 30-day mortality versus no IABP.

Result

Efficacy: 30-day all-cause mortalityRR 0.96 · P = 0.69

Below 1 favours intra-aortic balloon counterpulsation, above 1 favours no IABP.

Event rates
Absolute difference
1.6 points

The absolute difference is derived from the event rates.

Also reported: Persistent null at 1, 6 and 12 y.

Original publication
Subtopic
Mechanical support
Design
Multicentre RCT, Germany
Relevance
Practice-defining: a trial the field needs to know.
Source
Thiele H, et al. N Engl J Med. 2012;367(14):1287-1296.doi 10.1056/NEJMoa1208410

Discussion & critique

Retired routine IABP; guidelines downgraded to Class IIIa.